{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:47:55Z","timestamp":1792691275501,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF22OC0077893"],"award-info":[{"award-number":["NNF22OC0077893"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.radonc.2025.111096","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:14:44Z","timestamp":1755497684000},"page":"111096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Radiotherapy quality assurance of patients with squamous cell carcinoma of the head and neck included in the DAHANCA 19 randomised phase III trial"],"prefix":"10.1016","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5716-6069","authenticated-orcid":false,"given":"C.R.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8011-669X","authenticated-orcid":false,"given":"E.","family":"Sams\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Smulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4895-1080","authenticated-orcid":false,"given":"H.M.B.","family":"Sand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.I.S.","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Furre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2364-965X","authenticated-orcid":false,"given":"K.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3911-3929","authenticated-orcid":false,"given":"J.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9698-2082","authenticated-orcid":false,"given":"C.","family":"Maare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6250-0161","authenticated-orcid":false,"given":"C.A.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5.","family":"Bratland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3548-3527","authenticated-orcid":false,"given":"C.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1145-6033","authenticated-orcid":false,"given":"J.G.","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-8179","authenticated-orcid":false,"given":"J.","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111096_b0005","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2012.08.008","article-title":"QA makes a clinical trial stronger: evidence-based medicine in radiation therapy","volume":"105","author":"Weber","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jnci\/djt001","article-title":"Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials","volume":"105","author":"Ohri","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2025.111096_b0020","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijrobp.2005.05.021","article-title":"Design and implementation of an anthropomorphic quality assurance phantom for intensity-modulated radiation therapy for the Radiation Therapy Oncology Group","volume":"63","author":"Molineu","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111096_b0025","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.ijrobp.2007.08.083","article-title":"Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trials","volume":"71","author":"Ibbott","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111096_b0030","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1016\/S0167-8140(15)32870-X","article-title":"PD-0564: National dose audit of the quality of head and neck IMRT in the danish Head and Neck Cancer Group (DAHANCA)","volume":"106","author":"Hansen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0035","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3109\/0284186X.2015.1063780","article-title":"Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial","volume":"54","author":"Hansen","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0040","doi-asserted-by":"crossref","unstructured":"Eriksen JG, Maare C, Johansen J, Primdahl H, Bratland \u00c5, Kristensen CA, et al. DAHANCA19: A randomized phase III study of primary curative (chemo)-radiotherapy and the EGFR-inhibitor zalutumumab for squamous cell carcinoma of the head and neck. Radiother Oncol. 2025;Submitted.","DOI":"10.2139\/ssrn.4746948"},{"key":"10.1016\/j.radonc.2025.111096_b0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2017.09.019","article-title":"Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy","volume":"126","author":"Hansen","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2020.07.037","article-title":"The danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines","volume":"151","author":"Jensen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.radonc.2012.04.015","article-title":"EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility","volume":"103","author":"Fairchild","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2014.03.023","article-title":"Radiation therapy quality assurance in clinical trials\u2013Global Harmonisation Group","volume":"111","author":"Melidis","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0065","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/489\/1\/012100","article-title":"A DICOM based radiotherapy plan database for research collaboration and reporting","volume":"489","author":"Westberg","year":"2014","journal-title":"J Phys Conf Ser"},{"key":"10.1016\/j.radonc.2025.111096_b0070","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/0284186X.2023.2270143","article-title":"A national repository of complete radiotherapy plans: design, results, and experiences","volume":"62","author":"Krogh","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0075","article-title":"Danish and Swedish National Data Collections for Cancer - Solutions for Radiotherapy","volume":"37","author":"Olsson","year":"2024","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2025.111096_b0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/1754-9485.13374","article-title":"Plan quality in radiotherapy treatment planning - Review of the factors and challenges","volume":"66","author":"Hansen","year":"2022","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0085","article-title":"Recommendations for Radiotherapy Quality Assurance in Clinical Trials. Radioth","author":"Nielsen","year":"2025","journal-title":"Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2020.09.038","article-title":"What is plan quality in radiotherapy? the importance of evaluating dose metrics, complexity, and robustness of treatment plans","volume":"153","author":"Hernandez","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0095","article-title":"Applicability and usage of dose mapping\/accumulation in radiotherapy","volume":"109527","author":"Murr","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0100","first-page":"2","article-title":"Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans","volume":"1","author":"Hansen","year":"2016","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110200","article-title":"Neurological complications of modern radiotherapy for head and neck cancer","volume":"194","author":"Chow","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111096_b0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2012.07.005","article-title":"Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT phase III trial","volume":"104","author":"Gulliford","year":"2012","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025046006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025046006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:03:38Z","timestamp":1759521818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025046006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":22,"alternative-id":["S0167814025046006"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111096","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy quality assurance of patients with squamous cell carcinoma of the head and neck included in the DAHANCA 19 randomised phase III trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110899","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111096"}}